Open Access
September 2013 A Bayesian Dose-finding Design for Drug Combination Trials with Delayed Toxicities
Suyu Liu, Jing Ning
Bayesian Anal. 8(3): 703-722 (September 2013). DOI: 10.1214/13-BA839

Abstract

We propose a Bayesian adaptive dose-finding design for drug combination trials with delayed toxicity. We model the dose-toxicity relationship using the Finney model, a model widely used in drug-drug interaction studies. The intuitive interpretations of the Finney model facilitate incorporating the available prior dose-toxicity information from single-agent trials into combination trials through prior elicitation. We treat unobserved delayed toxicity outcomes as missing data and handle them using Bayesian data augmentation. We conduct extensive simulation studies to examine the operating characteristics of the proposed method under various practical scenarios. Results show that the proposed design is safe and able to select the target dose combinations with high probabilities.

Citation

Download Citation

Suyu Liu. Jing Ning. "A Bayesian Dose-finding Design for Drug Combination Trials with Delayed Toxicities." Bayesian Anal. 8 (3) 703 - 722, September 2013. https://doi.org/10.1214/13-BA839

Information

Published: September 2013
First available in Project Euclid: 9 September 2013

zbMATH: 1329.62431
MathSciNet: MR3102231
Digital Object Identifier: 10.1214/13-BA839

Keywords: adaptive design , Combining drugs , late-onset toxicity , maximum tolerated dose , missing data , phase I trial

Rights: Copyright © 2013 International Society for Bayesian Analysis

Vol.8 • No. 3 • September 2013
Back to Top